Aphea.Bio
PrivateLast Round
Grant
Sep 16, 2025
Total Funding Raised
$131.93M
Company Overview
Aphea.Bio is an agricultural biotechnology company that develops microorganism-based biostimulants and biocontrol products to enhance crop yields and health while promoting sustainable agricultural practices.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Sustainable Materials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aphea.Bio Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Aphea.Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 16, 2025 | ||||
| Grant | Nov 4, 2024 | ||||
| Series C | Jul 11, 2023 | ||||
| Series B | Apr 14, 2021 | ||||
| Series B | Nov 20, 2020 | ||||
Series A | Jun 26, 2017 |
Key People
Founding team and executive leadership
Aphea.Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Federal Holding and Investment Company | Series C |
| Sopartec | Series B, Series A |
| KU Leuven Research & Development (LRD) | Series B |
| Astanor Ventures | Series C, Series B |
| Korys | Series C |
| KU Leuven | Series A |
| V-Bio Ventures | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 11, 2023
$77M round completed.
- Jun 26, 2017
$1.46M grant received from VLAIO
Aphea.Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Aphea.Bio's valuation, stock price, and market status.